Why Abzena?
Trust our focused approach.
We offer product development and formulation programs to accelerate your timelines by leveraging our comprehensive in-house capabilities, technologies, and knowledge to deliver processes tailored to your molecule of interest.
We ensure the purity and integrity of your products by offering an extensive range of capabilities in the analytical method development (AMD) and QC departments.
We utilize quality by design (QbD) principles and follow ICH Product Lifecycle guidelines to develop processes for manufacturing at toxicology, clinical, and commercial scale.
For ADC, AOC, or RDC programs that arrive with existing methods, the team can execute seamless tech transfer or build an entirely new route when efficiency or safety demands it.
Abzena partners with you for seamless bioconjugate and chemistry projects, start to finish. Elevate development with our expertise, including bioconjugation and ADC services.
The development of antibody-drug conjugates (ADCs) and other bioconjugates requires a highly specialized chemistry team of experts. At Abzena, we have over 20 years of experience in complex chemistry, providing end-to-end support for the entire ADC lifecycle from discovery and design to development and clinical manufacturing.
Discover our complex chemistry expertise, including the design and synthesis of complex molecules such as cytotoxins and other linker payloads, for ADCs by downloading our info sheet today.
Whether you need a novel linker-payload, a pegylated nanoparticle, or an HPAPI manufactured under containment, the same end-to-end mindset applies tailored chemistry, rigorous control, and a direct line from first flask to validated commercial process. We adapt our approach to shorten lead times and develop risk mitigation strategies to ensure your overall success in delivering vital medicines to patients.